Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

  • Fergus J Couch
  • Mia M Gaudet
  • Antonis C Antoniou
  • Susan J Ramus
  • Karoline B Kuchenbaecker
  • Penny Soucy
  • Jonathan Beesley
  • Xiaoqing Chen
  • Xianshu Wang
  • Tomas Kirchhoff
  • Lesley McGuffog
  • Daniel Barrowdale
  • Andrew Roger Lee
  • Sue Healey
  • Olga M Sinilnikova
  • Irene L Andrulis
  • Hilmi Ozcelik
  • Anna Marie Mulligan
  • Mads Thomassen
  • Gerdes, Anne-Marie Axø
  • Uffe Birk Jensen
  • Anne-Bine Skytte
  • Torben A Kruse
  • Maria A Caligo
  • Anna von Wachenfeldt
  • Gisela Barbany-Bustinza
  • Niklas Loman
  • Maria Soller
  • Hans Ehrencrona
  • Per W. Karlsson
  • Katherine L Nathanson
  • Timothy R Rebbeck
  • Susan M Domchek
  • Ania Jakubowska
  • Jan Lubinski
  • Katarzyna Jaworska
  • Katarzyna Durda
  • Elzbieta Zlowocka
  • Tomasz Huzarski
  • Tomasz Byrski
  • Jacek Gronwald
  • Cezary Cybulski
  • Bohdan Górski
  • Ana Osorio
  • Mercedes Durán
  • María Isabel Tejada
  • Javier Benitez
  • Ute Hamann
  • Frans B L Hogervorst
  • Nielsen, Finn Cilius
  • OCGN
Genome-wide association studies (GWAS) identified variants at 19p13.1 and ZNF365 (10q21.2) as risk factors for breast cancer among BRCA1 and BRCA2 mutation carriers, respectively. We explored associations with ovarian cancer and with breast cancer by tumor histopathology for these variants in mutation carriers from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).
OriginalsprogEngelsk
TidsskriftCancer Epidemiology, Biomarkers & Prevention
Vol/bind21
Udgave nummer4
Sider (fra-til)645-57
Antal sider13
ISSN1055-9965
DOI
StatusUdgivet - 2012

ID: 48450631